SG11202005138TA - Imidazopyridine derivatives and the use thereof as medicament - Google Patents

Imidazopyridine derivatives and the use thereof as medicament

Info

Publication number
SG11202005138TA
SG11202005138TA SG11202005138TA SG11202005138TA SG11202005138TA SG 11202005138T A SG11202005138T A SG 11202005138TA SG 11202005138T A SG11202005138T A SG 11202005138TA SG 11202005138T A SG11202005138T A SG 11202005138TA SG 11202005138T A SG11202005138T A SG 11202005138TA
Authority
SG
Singapore
Prior art keywords
medicament
imidazopyridine derivatives
imidazopyridine
derivatives
Prior art date
Application number
SG11202005138TA
Other languages
English (en)
Inventor
Riccardo Giovannini
Angelo Ceci
Georg Dahmann
Cornelia Dorner-Ciossek
Lothar Kussmaul
Roland Pfau
Dieter Wiedenmayer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG11202005138TA publication Critical patent/SG11202005138TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
SG11202005138TA 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament SG11202005138TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17206152 2017-12-08
PCT/EP2018/083728 WO2019110703A1 (en) 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament

Publications (1)

Publication Number Publication Date
SG11202005138TA true SG11202005138TA (en) 2020-06-29

Family

ID=60629568

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005138TA SG11202005138TA (en) 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament

Country Status (31)

Country Link
US (1) US10849907B2 (es)
EP (1) EP3720855B1 (es)
JP (1) JP6941235B2 (es)
KR (1) KR20200097301A (es)
CN (1) CN111344291B (es)
AR (1) AR113923A1 (es)
AU (1) AU2018379438B2 (es)
BR (1) BR112020008583A2 (es)
CA (1) CA3083331A1 (es)
CL (1) CL2020001402A1 (es)
CO (1) CO2020006648A2 (es)
CY (1) CY1124744T1 (es)
DK (1) DK3720855T3 (es)
EA (1) EA202091139A1 (es)
ES (1) ES2897050T3 (es)
HR (1) HRP20211726T1 (es)
HU (1) HUE056667T2 (es)
IL (1) IL274868B1 (es)
LT (1) LT3720855T (es)
MA (1) MA51020B1 (es)
MX (1) MX2020005869A (es)
PE (1) PE20211454A1 (es)
PL (1) PL3720855T3 (es)
PT (1) PT3720855T (es)
RS (1) RS62517B1 (es)
SA (1) SA520412155B1 (es)
SG (1) SG11202005138TA (es)
SI (1) SI3720855T1 (es)
TW (1) TWI809014B (es)
UA (1) UA126247C2 (es)
WO (1) WO2019110703A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020245137A1 (en) * 2019-06-04 2020-12-10 Boehringer Ingelheim International Gmbh Imidazopyrazine derivatives and the use thereof as medicament
TW202112378A (zh) * 2019-06-04 2021-04-01 德商百靈佳殷格翰國際股份有限公司 嘌呤衍生物及其作為藥物之用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
IL159393A (en) 2001-07-24 2011-01-31 Richter Gedeon Vegyeszet Piperidine derivatives, pharmaceutical compositions containing them, processes for their preparation and uses thereof
US20110319416A1 (en) 2009-01-28 2011-12-29 Emory University Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
AU2013333988B2 (en) 2012-10-18 2017-03-09 F. Hoffmann-La Roche Ag Ethynyl derivatives as modulators of mGluR5 receptor activity
JP6577479B2 (ja) 2014-02-27 2019-09-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Nav チャンネル阻害剤としてのヘテロ環化合物及びその使用
US10030026B2 (en) * 2014-06-04 2018-07-24 Rugen Holdings (Cayman) Limited Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists
US10913736B2 (en) 2014-08-22 2021-02-09 University Of Washington Specific inhibitors of methionyl-tRNA synthetase
CN106715435B (zh) * 2014-09-15 2019-10-01 卢郡控股(开曼)有限公司 作为nr2b nmda受体拮抗剂的吡咯并嘧啶衍生物

Also Published As

Publication number Publication date
US20190175605A1 (en) 2019-06-13
HUE056667T2 (hu) 2022-02-28
LT3720855T (lt) 2021-11-10
CN111344291A (zh) 2020-06-26
MX2020005869A (es) 2020-09-09
EP3720855B1 (en) 2021-08-25
TWI809014B (zh) 2023-07-21
MA51020B1 (fr) 2021-10-29
TW201936198A (zh) 2019-09-16
CA3083331A1 (en) 2019-06-13
EP3720855A1 (en) 2020-10-14
PE20211454A1 (es) 2021-08-05
IL274868A (en) 2020-07-30
MA51020A (fr) 2021-05-26
AU2018379438A1 (en) 2020-05-07
PL3720855T3 (pl) 2022-01-24
CY1124744T1 (el) 2022-07-22
PT3720855T (pt) 2021-11-03
JP6941235B2 (ja) 2021-09-29
WO2019110703A1 (en) 2019-06-13
ES2897050T3 (es) 2022-02-28
JP2021505584A (ja) 2021-02-18
CN111344291B (zh) 2023-05-05
CL2020001402A1 (es) 2020-09-21
AU2018379438B2 (en) 2022-08-18
US10849907B2 (en) 2020-12-01
SA520412155B1 (ar) 2022-06-05
EA202091139A1 (ru) 2020-11-23
BR112020008583A2 (pt) 2020-10-20
IL274868B1 (en) 2024-02-01
RS62517B1 (sr) 2021-11-30
KR20200097301A (ko) 2020-08-18
UA126247C2 (uk) 2022-09-07
HRP20211726T1 (hr) 2022-02-18
SI3720855T1 (sl) 2021-12-31
AR113923A1 (es) 2020-07-01
DK3720855T3 (da) 2021-11-08
CO2020006648A2 (es) 2020-06-09

Similar Documents

Publication Publication Date Title
IL246757B (en) New insulin histories and their medical uses
IL257173A (en) New insulin histories and their medical uses
PL3421038T3 (pl) Związek naftyrydyny, kompozycja farmaceutyczna i ich zastosowanie
GB201617064D0 (en) Compounds and their therapeutic use
GB201715194D0 (en) Compounds and their therapeutic use
HUE059878T2 (hu) Készítmény és gyógyszerek lokális zsír és testtömeg csökkentésére és ezek alkalmazása
IL282527A (en) 5-Azaindazole history and their use
IL274868A (en) History of imidazopyridine and their use as medicine
IL282526A (en) 5-Azaindazole history and their use
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
IL282142A (en) The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine
ZA201607353B (en) Bicyclic derivatives and pharmaceutical composition including the same
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
PL3250181T3 (pl) Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw
EP3192513A4 (en) 7-fluoro-8-chloro-5 -dibenzo[b,e][1,4]diazepine derivatives and use thereof
HK1251558A1 (zh) 新的酰亞胺衍生物及其作為藥物的用途
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
PT3606534T (pt) Derivados de fosfolípidos e sua utilização como medicamentos